Ioxilan

Ioxilan is a low-osmolar, nonionic and tri-iodinated diagnostic contrast agent. Ioxilan is also an X-ray contrast agent for excretory urography and contrast enhanced computed tomographic (CECT) imaging of the head and body. Intravascular injection results in opacification of vessels in the path of flow of the contrast medium, permitting radiographic visualization of the internal structures of the human body until significant hemodilution occurs[1][2][3].

Product Specifications

CAS Number

[107793-72-6]

UNSPSC

12352005

Hazard Statement

H315, H319, H320

Target

Biochemical Assay Reagents

Type

Reference compound

Related Pathways

Others

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/ioxilan.html

Purity

98.34

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(C1=C(I)C(N(C(C)=O)CC(O)CO)=C(I)C(C(NCCO)=O)=C1I)NCC(O)CO

Molecular Formula

C18H24I3N3O8

Molecular Weight

791.11

Precautions

H315, H319, H320

References & Citations

[1]Cheng KT. Ioxilan carbonate particles. National Center for Biotechnology Information (US) ; 2004-2013. 2007 Sep 1.|[2]Chow SL, et al. Effect of iodixanol and ioxilan on QT interval and renal function in patients with systolic heart failure. Int J Cardiol. 2012 Jan 12;154 (1) :17-21.|[3] Nonionic Contrast Agents.